| Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
|---|
| 08/08/2001 | EP1121432A2 G-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
| 08/08/2001 | EP1121431A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 08/08/2001 | EP1121430A1 Human isre-binding protein |
| 08/08/2001 | EP1121428A2 Genes, proteins and biallelic markers related to central nervous system disease |
| 08/08/2001 | EP1121427A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 08/08/2001 | EP1121425A1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/08/2001 | EP1121422A2 Terpene synthases |
| 08/08/2001 | EP1121419A1 Tnfr related gene 12 |
| 08/08/2001 | EP1121415A1 Photobioreactor |
| 08/08/2001 | EP1121382A2 Interferon-beta fusion proteins and uses |
| 08/08/2001 | EP1121374A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 08/08/2001 | EP1121331A1 Microbiological method for eliminating a nitroaromatic compound |
| 08/08/2001 | EP1121150A1 Delta 6 fatty acid desaturase |
| 08/08/2001 | EP0941137B1 Decomposition of halogenated hydrocarbons by halophilic archae bacteria |
| 08/08/2001 | EP0726949B1 Opioid receptor: compositions and methods |
| 08/08/2001 | CN1307642A Method for producing polypeptide by modifying copy number of gene |
| 08/08/2001 | CN1307638A Host-encoded protein expressed on Marek's disease (MDV)-infected cells and antibody thereto |
| 08/08/2001 | CN1307637A Polynucleotides isolated from skin cells and methods for their use |
| 08/08/2001 | CN1307484A Antibodies against human CD40 |
| 08/08/2001 | CN1307482A Utilization of interferon alpha 5 in the treatment of viral hepatopathies |
| 08/08/2001 | CN1307449A Novel biocontrol agents |
| 08/08/2001 | CN1307129A Method for producing recombinant glucokinase |
| 08/08/2001 | CN1307100A Process for preparing vaccine for Mycobacterium vaccae |
| 08/08/2001 | CN1069346C Expression and secretion of hereologous proteins by yarrowia lipolytica transformants |
| 08/08/2001 | CN1069345C Solvent entraction of polyhydroxyalkanoates from biomass by using critical nonsolvent polyhydroxyalkanoates |
| 08/08/2001 | CN1069216C Process for production of attenuated varicella zoster virus vaccine |
| 08/07/2001 | US6271440 Plant regulatory proteins III |
| 08/07/2001 | US6271368 Nucleotide sequences coding moduator of cellular activities; for the use in the prevention of plant consumption; viricides |
| 08/07/2001 | US6271365 Activin like receptor--Isolated kinase proteins ALK-2, ALK-4, ALK-5, and nucleic acid molecules encoding them |
| 08/07/2001 | US6271353 Antibodies specific for human adseverin |
| 08/07/2001 | US6271341 Fusion protein associated with the control of gene expression; for use as a tool in controlled gene expression |
| 08/07/2001 | US6271267 Compound to regulate the morphological transition of dimorphic candida |
| 08/07/2001 | US6271197 Administering a geranylgeranyl transferase inhibitor |
| 08/07/2001 | US6271175 Grass treatment |
| 08/07/2001 | US6271034 One step allelic exchange in mycobacteria using in vitro generated conditional transducing phages |
| 08/07/2001 | US6271027 Cell and tissue culture device with enhanced culture fluid flow |
| 08/07/2001 | US6271019 Leukemia associated genes |
| 08/07/2001 | US6271018 Muskmelon (Cucumis melo) hydroperoxide lyase and uses thereof |
| 08/07/2001 | US6271017 Genes of Heliciobacter pylori necessary for the regulation and maturation of urease and their use |
| 08/07/2001 | US6271014 A polypeptide with proteolytic activity; therapy for periodontal disease, rheumatoid arthritis, aging, cancer, wound healing, bone resorption, pregnancy and parturition |
| 08/07/2001 | US6271013 A phenylalanine aminopeptidase and/or leucine aminopeptidase having 10 times more activity; preparation of bread doughs and cheeses |
| 08/07/2001 | US6271007 Yeast strains for the production of xylitol |
| 08/07/2001 | US6271000 Streptococcus pneumoniae gene sequence mraY |
| 08/07/2001 | US6270998 An isolated nucleic acid involved in apoptosis; diagnosis and therapy of diseases associated with human immunodeficiency virus; antitumor agents |
| 08/07/2001 | US6270994 Smad6 and uses thereof |
| 08/07/2001 | US6270993 VEGF-binding polypeptide |
| 08/07/2001 | US6270992 Histidine kinase of Staphylococcus aureus |
| 08/07/2001 | US6270988 Transforming escherichia host cells with an extrachromosomal expression vector containing a dna sequence coding a transfer rna for arginine incorporation into proteins; treating the transformed cells resulting in favorable protein production |
| 08/07/2001 | US6270969 Recombinational cloning using engineered recombination sites |
| 08/07/2001 | US6270964 Polypeptide used a diagnostic tool in genetic engineering |
| 08/07/2001 | US6270960 Detecting microorganism in sample; incubate sample with preferential polypeptide and detect binding of preferential antibody |
| 08/07/2001 | US6270956 Polypeptide activator of gene expression; for use in treatment of preferential viral diseases and infections; for the detection of modulators of gene expression |
| 08/07/2001 | US6270816 Human foodstuffs are produced commercially from fusarium which is a haploid fungus. a particularly suitable strain of fusarium a3/5, imi 145425. |
| 08/07/2001 | US6270776 Recombinant mycobacterial vaccine |
| 08/07/2001 | US6270772 Mhc class ii based molecules that comprise covalently linked beta 1 and alpha 1 domains, and mhc class i based molecules that comprise covalently linked alpha 1 and alpha 2 domains. |
| 08/07/2001 | US6270768 Azithromycins |
| 08/07/2001 | US6270763 Recombinant products are useful for diagnosis of allergy and for therapeutic treatment of allergy. |
| 08/07/2001 | US6270760 Production of Bacillus thuringiensis integrants |
| 08/07/2001 | CA2080781C Method for the culture of microorganisms of the genera helicobacter, campylobacter and arcobacter employing culture media comprising cyclodextrins, methylcellulose or mixtures thereof |
| 08/02/2001 | WO2001055449A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055448A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055447A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055444A1 Method for the evaluation of implantable materials |
| 08/02/2001 | WO2001055441A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055432A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | WO2001055430A1 17 human secreted proteins |
| 08/02/2001 | WO2001055411A2 Human sulfatases |
| 08/02/2001 | WO2001055397A1 NOVEL POLYPEPTIDES VraS AND VraR |
| 08/02/2001 | WO2001055396A1 NOVEL POLYPEPTIDES HmrA AND HmrB |
| 08/02/2001 | WO2001055393A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1 |
| 08/02/2001 | WO2001055392A2 Nuclear hormone receptors |
| 08/02/2001 | WO2001055391A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 08/02/2001 | WO2001055389A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 08/02/2001 | WO2001055388A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055387A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055368A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055367A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055364A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055363A1 Process for producing lactic acid |
| 08/02/2001 | WO2001055358A2 Phosphodiesterases |
| 08/02/2001 | WO2001055356A2 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | WO2001055355A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055350A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055344A2 Culture medium for microorganisms |
| 08/02/2001 | WO2001055343A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055337A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | WO2001055336A2 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055333A2 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | WO2001055329A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055328A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055327A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055326A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055325A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055324A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055323A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055322A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055321A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055320A2 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | WO2001055319A2 Endocrine related nucleic acids, proteins and antibodies |
| 08/02/2001 | WO2001055318A2 Nucleic acids, proteins, and antibodies |